English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Inhibiting two pore channels by tetrandrine induces expansion of TNFR2+CD4+Foxp3+ regulatory T cells Journal article
He, T., Yang, D., Li, X., Chen, S., Chen, Y., Chou, C., Trivett, A., Oppenheim, J, Chen, X.. Inhibiting two pore channels by tetrandrine induces expansion of TNFR2+CD4+Foxp3+ regulatory T cells[J]. Science Advances, 2020, 1-13.
Authors:  He, T.;  Yang, D.;  Li, X.;  Chen, S.;  Chen, Y.; et al.
Favorite |   IF:11.7/13.7 | Submit date：2022/08/30
tetrandrine  Treg  TNFR2  
Two pore channel inhibitor tetrandrine promotes TNF-TNFR2 interaction resulting in proliferative expansion of CD4+Foxp3+ regulatory T cells Presentation
会议地点: Keystone meeting (Innate Immune Receptors: Roles in Immunology and Beyond), 报告日期: 2019-03-12
Authors:  He, T;  Trivett, A.;  Li, X.;  Yang, D.;  Oppenheim, J.; et al.
Favorite |  | Submit date：2022/08/30
Development of a Curative Therapeutic Vaccine (TheraVac) for the Treatment of Big Solid Tumors Journal article
Nie, Y.J., Yang, D., Trivett, A., Xin, H.Y., Han, Zh., Chen, X., Oppenheim, J.. Development of a Curative Therapeutic Vaccine (TheraVac) for the Treatment of Big Solid Tumors[J]. Scientific reports, 2017, 1-12.
Authors:  Nie, Y.J.;  Yang, D.;  Trivett, A.;  Xin, H.Y.;  Han, Zh.; et al.
Favorite |   IF:3.8/4.3 | Submit date：2022/08/30
CT26 tumors  immunotherapeutic  tumor-specific immunity